Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xinxinfu + Qiangxin Fang is a combination therapy consisting of a cardiac rehabilitation program (Xinxinfu) and a traditional Chinese herbal formula (Qiangxin Fang). Developed by the Shanghai Municipal Hospital of Traditional Chinese Medicine and the Shanghai Shenkang Hospital Development Center, this integrative approach is used to treat coronary heart disease complicated by cardiac insufficiency (heart failure). The Xinxinfu component typically involves structured cardiac rehabilitation exercises and lifestyle interventions, while Qiangxin Fang is an herbal prescription aimed at strengthening the heart and improving circulation. This combination is studied as an adjunct to standard Western medical therapy to improve clinical outcomes, exercise tolerance, and quality of life in patients with heart failure.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Xinxinfu + Qiangxin Fang.